Faustine Ong

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Faustine Ong is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, acute myeloid leukemia therapy, and hematologic malignancy therapy.

ORCID

Publications per year

2023–2024

Publications

A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents

Nicholas J. Short, Muharrem Müftüoğlu, Faustine Ong et al. · Journal of Hematology & Oncology · 2023 · 50 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation

Nicholas J. Short, Faustine Ong, Farhad Ravandi et al. · Blood Advances · 2023 · 24 citations · Full text

Medicine, Geriatric Medicine, Hematology +14

Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis

Fadi Haddad, Koji Sasaki, Jayastu Senapati et al. · JCO Oncology Practice · 2024 · 11 citations

Medicine, Hematology, Oncology +15

Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms

Kelly S. Chien, Faustine Ong, Kunhwa Kim et al. · Cancer Medicine · 2024 · 10 citations · Full text

Medicine, Hematology, Oncology +13

1–4 of 4